Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
2007
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules
2004 StandoutNobel
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress
2003
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
2010 Standout
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Inflammation-associated cancer: NF-κB is the lynchpin
2005
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
Macrophage polarization in tumour progression
2008
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Interleukin-12-induced Interferon-γ Production by Human Peripheral Blood T Cells Is Regulated by Mammalian Target of Rapamycin (mTOR)
2004
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Interferon–Alpha Suppresses the Antiapoptotic Effect of NF–kB and Sensitizes Renal Cell Carcinoma Cells in vitro to Chemotherapeutic Drugs
2001
The biology and function of fibroblasts in cancer
2016 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Repertoire of microglial and macrophage responses after spinal cord injury
2011 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Control of apoptosis by Rel/NF-κB transcription factors
1999
Putting tumours in context
2001 Standout
T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets
2010
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
2004
Notch and the Immune System
1999
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma
2005
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
B7-H1 glycoprotein blockade: A novel strategy to enhance immunotherapy in patients with renal cell carcinoma
2005
Aberrant rel/nfkb genes and activity in human cancer
1999
Vaccine and antibody-directed T cell tumour immunotherapy
2004
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes from Transforming Growth Factor-β-induced Growth Inhibition and Apoptosis
2000
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
NF-κB at the crossroads of life and death
2002 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
2004
Significance of B7-H1 Overexpression in Kidney Cancer
2006
Fas Ligand–Positive Membranous Vesicles Isolated from Sera of Patients with Oral Cancer Induce Apoptosis of Activated T Lymphocytes
2005
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
2008
Roles for NF-κB in nerve cell survival, plasticity, and disease
2006
The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes
2000
Identification of Notch1 as a Frequent Target for Provirus Insertional Mutagenesis in T-Cell Lymphomas Induced by Leukemogenic Mutants of Mouse Mammary Tumor Virus
2000 StandoutNobel
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function.
2001
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide
2001
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
2006
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
2003
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
2005
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic Readiness
2015 StandoutNobel
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Recombination signal sequence-binding protein Jκ alters mesodermal cell fate decisions by suppressing cardiomyogenesis
2003 StandoutNobel
Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection
2016
Works of Tracy Bloom being referenced
Alterations in NF B Activation in T Lymphocytes of Patients With Renal Cell Carcinoma
1999
Renal cell carcinoma–derived gangliosides suppress nuclear factor-κB activation in T cells
1999
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
1999
Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3.
1999
Inhibition of NF-κB Activity in Human T Lymphocytes Induces Caspase-Dependent Apoptosis Without Detectable Activation of Caspase-1 and -3
1999
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
1998